x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Heart Matters

Since cardiovascular disease is one of the leading causes of death in the U.S., cardiology physicians are continuously working to better understand this common disease and to help patients improve their heart health. And here to assist cardiology physicians in this mission is Heart Matters, a series dedicated to covering essential strategies and research efforts focusing on all types of heart problems, including coronary artery diseases, heart attacks, high cholesterol, high blood pressure, and

science & medicine medicine

All Episodes

00:00:00

Updates from ACC 2023: Examining Transcatheter Repair...

Heart Matters ·

2023/03/29

Guest: Paul Sorajja, MD TRILUMINATE was the first trial to take a look at the impact of tricuspid regurgitation (TR) reduction on patients, and its results may lead to significant improvements in care and quality of life. To learn more about this trial, Dr. Paul Sorajja from the Minneapolis Heart Institute Foundation details the key findings from this trial and explores their impact.

en

00:00:00

Updates from ACC 2023: Examining Transcatheter Repair...

Heart Matters ·

2023/03/29

Guest: Paul Sorajja, MD TRILUMINATE was the first trial to take a look at the impact of tricuspid regurgitation (TR) reduction on patients, and its results may lead to significant improvements in care and quality of life. To learn more about this trial, Dr. Paul Sorajja from the Minneapolis Heart Institute Foundation details the key findings from this trial and explores their impact.

en

00:00:00

Cardio-Oncology: Key Clinical Data from ACC.23

Heart Matters ·

2023/03/23

Guest: Ana Barac, MD, PhD The American College of Cardiology's 72nd Scientific Session & Expo featured the latest advancements in all fields of cardiovascular medicine, including cardio-oncology. To learn more, Dr. Javed Butler sits down with Dr. Ana Barac from the MedStar Washington Hospital Center to take a look at clinical data from the STOP-CA trial.

en

00:00:00

The Emerging Field of Cardio-Oncology: A Look at the...

Heart Matters ·

2023/03/17

Host: Javed Butler, MD, MBA, MPH Guest: Ana Barac, MD, PhD Cardio-oncology is a novel field in cardiovascular medicine that has rapidly grown over the past few years. What kind of role does multidisciplinary care have in it? Dr. Javed Butler is joined by Dr. Ana Barac from the Inova Heart and Vascular Institute to take a look at where cardio-oncology is and where it could be headed.

en

00:00:00

The Emerging Field of Cardio-Oncology: A Look at the...

Heart Matters ·

2023/03/17

Host: Javed Butler, MD Guest: Ana Barac, MD, PhD Cardio-oncology is a novel field in cardiovascular medicine that has rapidly grown over the past few years. What kind of role does multidisciplinary care have in it? Dr. Javed Butler is joined by Dr. Ana Barac from the Inova Heart and Vascular Institute to take a look at where cardio-oncology is and where it could be headed.

en

00:00:00

A Look at Lipoprotein(a): Key Screening & Treatment...

Heart Matters ·

2023/03/03

According to the CDC, patients with familial hypercholesterolemia or patients who show signs of coronary heart disease are at an increased chance of having heart attack, stroke, and aortic stenosis due to high levels of lipoprotein(a). So how can me manage lipoprotein(a) in our patients? To discuss this, Dr. Mary Katherine Cheeley is joined by fellow ReachMD host Dr. Alan Brown, who’s also the Director of the Division of Cardiology and the Lipid Clinic at Advocate Lutheran General

en

00:00:00

A Look at Lipoprotein(a): Key Screening & Treatment...

Heart Matters ·

2023/03/03

According to the CDC, patients with familial hypercholesterolemia or patients who show signs of coronary heart disease are at an increased chance of having heart attack, stroke, and aortic stenosis due to high levels of lipoprotein(a). So how can me manage lipoprotein(a) in our patients? To discuss this, Dr. Mary Katherine Cheeley is joined by fellow ReachMD host Dr. Alan Brown, who’s also the Director of the Division of Cardiology and the Lipid Clinic at Advocate Lutheran General

en

00:00:00

Anticipated Updates on Statin Intolerance at ACC 2023

Heart Matters ·

2023/03/02

Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA Guest: Kevin C. Maki, PhD, FNLA, CLS At the American College of Cardiology's 72nd Annual Scientific Session & Expo, cardiologists will gather to explore the latest advancements in the field. Joining us to share what you can expect to learn about statin intolerance at their upcoming session are Dr. Mary Katherine Cheeley and Dr. Kevin Maki.

en

00:00:00

Anticipated Updates on Statin Intolerance at ACC 2023

Heart Matters ·

2023/03/02

Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA Guest: Kevin C. Maki, PhD, FNLA, CLS At the American College of Cardiology's 72nd Annual Scientific Session & Expo, cardiologists will gather to explore the latest advancements in the field. Joining us to share what you can expect to learn about statin intolerance at their upcoming session are Dr. Mary Katherine Cheeley and Dr. Kevin Maki.

en

00:00:00

The Role of Implementation Science in Familial...

Heart Matters ·

2023/01/05

Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA Guest: Laney K. Jones, PharmD, MPH Patients with familial hypercholesterolemia (FH) are at an increased risk of developing coronary heart disease at a young age. So what’s on the horizon for using implementation science strategies in treating patients with FH? Learn more about implementation science as Dr. Mary Katherine Cheeley discusses this with Dr. Laney Jones, Associate Professor at Geisinger’s Department of Genomic

en

00:00:00

The Role of Implementation Science in Familial...

Heart Matters ·

2023/01/05

Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA Guest: Laney K. Jones, PharmD, MPH Patients with familial hypercholesterolemia (FH) are at an increased risk of developing coronary heart disease at a young age. So what’s on the horizon for using implementation science strategies in treating patients with FH? Learn more about implementation science as Dr. Mary Katherine Cheeley discusses this with Dr. Laney Jones, Associate Professor at Geisinger’s Department of Genomic

en

00:00:00

Updated Guidelines for Youth With Dyslipidemia

Heart Matters ·

2022/12/15

Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA Guest: Lauren Williams, MCN,RD,LD Kids with dyslipidemia don’t have much different nutritional needs than other young kids their age. However, there are a few key things to be aware of. So how can clinicians meet families where they are to improve their diet? Dive into the unique needs of youth with dyslipidemia as Dr. Mary Katherine Cheeley is joined by Lauren Williams, Class II Clinical Dietician at Cook Children’s Health

en

00:00:00

Updated Guidelines for Youth With Dyslipidemia

Heart Matters ·

2022/12/15

Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA Guest: Lauren Williams, MCN,RD,LD Kids with dyslipidemia don’t have much different nutritional needs than other young kids their age. However, there are a few key things to be aware of. So how can clinicians meet families where they are to improve their diet? Dive into the unique needs of youth with dyslipidemia as Dr. Mary Katherine Cheeley is joined by Lauren Williams, Class II Clinical Dietician at Cook Children’s Health

en

00:00:00

A Look into the Effectiveness of Dietary Supplements

Heart Matters ·

2022/12/07

Host: Matthew Sorrentino, MD Guest: Luke Laffin, MD Six commonly used supplements thought to improve patients’ cholesterol may be doing more harm than good. So what do we need to know about these supplements? To walk us through the results of the SPORT trial, Dr. Matthew Sorrentino is joined by Dr. Luke Laffin, Co-Director of the Center for Blood Pressure Disorders at the Cleveland Clinic.

en

00:00:00

A Look into the Effectiveness of Dietary Supplements

Heart Matters ·

2022/12/07

Host: Matthew Sorrentino, MD Guest: Luke Laffin, MD Six commonly used supplements thought to improve patients’ cholesterol may be doing more harm than good. So what do we need to know about these supplements? To walk us through the results of the SPORT trial, Dr. Matthew Sorrentino is joined by Dr. Luke Laffin, Co-Director of the Center for Blood Pressure Disorders at the Cleveland Clinic.

en

00:00:00

Uncovering the Results of the DELIVER Trial

Heart Matters ·

2022/11/09

Host: Javed Butler, MD, MBA, MPH Guest: Scott Solomon, MD Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction (DELIVER trial) is a study designed to assess the effectiveness of SGLT2 inhibitors in patients with higher left ventricular ejection fraction. To help lead the discussion on the results of this study, Dr. Javed Butler is joined by Dr. Scott Solomon, lead study author and Director of the Clinical Trials Outcomes Center and the Edward D

en

00:00:00

Uncovering the Results of the DELIVER Trial

Heart Matters ·

2022/11/09

Host: Javed Butler, MD Guest: Scott Solomon, MD Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction (DELIVER trial) is a study designed to assess the effectiveness of SGLT2 inhibitors in patients with higher left ventricular ejection fraction. To help lead the discussion on the results of this study, Dr. Javed Butler is joined by Dr. Scott Solomon, lead study author and Director of the Clinical Trials Outcomes Center and the Edward D. Frohlich

en

00:00:00

Investigating the Link Between PCOS & CV Risk Factors...

Heart Matters ·

2022/08/09

Host: Hector O. Chapa, MD, FACOG Guest: Erin D. Michos, MD, MHS, FACC, FAHA, FASE Polycystic ovary syndrome (PCOS) affects approximately 5 to 13 percent of women in the general population. And although previous research has shown its link to cardiovascular (CV) risk factors later in life, a new study has revealed that PCOS can increase the risk of heart complications during delivery. So what do these findings mean when it comes to caring for pregnant patients with PCOS? Find out

en

00:00:00

Investigating the Link Between PCOS & CV Risk Factors...

Heart Matters ·

2022/08/09

Host: Hector O. Chapa, MD, FACOG Guest: Erin Michos Polycystic ovary syndrome (PCOS) affects approximately 5 to 13 percent of women in the general population. And although previous research has shown its link to cardiovascular (CV) risk factors later in life, a new study has revealed that PCOS can increase the risk of heart complications during delivery. So what do these findings mean when it comes to caring for pregnant patients with PCOS? Find out with Dr. Hector Chapa as he’s

en

00:00:00

When Climate & Cardiology Overlap: How Climate Change...

Heart Matters ·

2022/08/05

Host: Javed Butler, MD, MBA, MPH Guest: Sameed Khatana, MD, MPH As global temperatures continue to rise, experts are calling attention to the devastating effects this can have on human health. Cardiovascular mortality is especially a concern, as two recent studies from the University of Pennsylvania outlined the connection between these two health risks. To learn more about how climate change can impact our cardiovascular health, Dr. Javed Butler is joined by Dr. Sameed Khatana,

en

320 results

Similar Podcasts

科学史评话最新专辑

科学史评话

Hablando con Científicos - Cienciaes.com

cienciaes.com

天方烨谈

基因频道

The Permaculture Podcast

Scott Mann

汪诘：科学有故事（主打）

科学有故事